Stephen J. Schuster MD

Dr. Stephen J. Schuster, M.D. serves as the Robert and Margarita Louis-Dreyfus Professor in Chronic Lymphocytic Leukemia and Lymphoma Clinical Care and Research. He serves as Director of the Lymphoma Program at the Abramson Cancer Center of the University of Pennsylvania. Dr. Schuster has been a Member of Scientific Advisory Board at Nordic Nanovector ASA since May 2015. Dr. Schuster serves as Member of Scientific Advisory Board at Biovest International Inc. and is instrumental in the clinical development of BiovaxID, presenting vaccine trial results at major peer-review cancer meetings including at the American Society of Clinical Oncology (ASCO) and at the American Society of Hematology (ASH).